EUVIMEDEUVIMED entdecken
Open Access

Amino Acid Metabolism-Regulated Nanomedicine for Enhanced Tumor Immunotherapy through Synergistic Regulation of Immune Microenvironment

Xiuying Duan, Yilei Zhao, Houyang Hu, Xuechun Wang, Jie Yan, Songyan Li, Yueying Zhang, Jianwei Jiao, Guiqiang Zhang iD

Biomaterials Research · 01.01.2024 · 28

DOI: 10.34133/bmr.0048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 04.07.2024. Verfasst von Xiuying Duan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, C…. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China, Project for Scientific Research Innovation Team of Young Scholars in Colleges and Universities of Shandong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The reprogramming of tumor metabolism presents a substantial challenge for effective immunotherapy, playing a crucial role in developing an immunosuppressive microenvironment. In particular, the degradation of the amino acid L-tryptophan (Trp) to kynurenine (Kyn) by indoleamine-pyrrole 2,3-dioxygenase 1 (IDO1) is one of the most clinically validated pathways for immune suppression. Thus, regulating the Trp/Kyn metabolism by IDO1 inhibition represents a promising strategy for enhancing immunotherapy. Herein, metabolism-regulated nanoparticles are prepared through metal coordination-driven assembly of an IDO1 inhibitor (NLG919) and a stimulator of interferon genes (STING) agonist (MSA-2) for enhanced immunotherapy. After intravenous administration, the assembled nanoparticles could efficiently accumulate in tumors, enhancing the bioavailability of NLG919 and down-regulating the metabolism of Trp to Kyn to remodel the immunosuppressive tumor microenvironment. Meanwhile, the released MSA-2 evoked potent STING pathway activation in tumors, triggering an effective immune response. The antitumor immunity induced by nanoparticles significantly inhibited the development of primary and metastatic tumors, as well as B16 melanoma. Overall, this study provided a novel paradigm for enhancing tumor immunotherapy through synergistic amino acid metabolism and STING pathway activation.

Autor:innen und Institutionen

  • Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
  • School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
  • School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
  • State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.

ORCID-Profile: Guiqiang Zhang

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China
  • Project for Scientific Research Innovation Team of Young Scholars in Colleges and Universities of Shandong Province
  • Shandong Traditional Chinese Medicine Technology Project

Zitieren

APA

Duan, X., Zhao, Y., Hu, H., Wang, X., Yan, J., Li, S., Zhang, Y., Jiao, J., & Zhang, G. (2024). Amino Acid Metabolism-Regulated Nanomedicine for Enhanced Tumor Immunotherapy through Synergistic Regulation of Immune Microenvironment. Biomaterials Research, 28. https://doi.org/10.34133/bmr.0048

Vancouver

Duan X, Zhao Y, Hu H, Wang X, Yan J, Li S, et al. Amino Acid Metabolism-Regulated Nanomedicine for Enhanced Tumor Immunotherapy through Synergistic Regulation of Immune Microenvironment. Biomaterials Research. 2024;28. doi:10.34133/bmr.0048

BibTeX
@article{Duan2024,
  author = {Duan, Xiuying and Zhao, Yilei and Hu, Houyang and Wang, Xuechun and Yan, Jie and Li, Songyan and Zhang, Yueying and Jiao, Jianwei and Zhang, Guiqiang},
  title = {Amino Acid Metabolism-Regulated Nanomedicine for Enhanced Tumor Immunotherapy through Synergistic Regulation of Immune Microenvironment},
  journal = {Biomaterials Research},
  year = {2024},
  volume = {28},
  doi = {10.34133/bmr.0048}
}
Kostenlos starten →